This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK Malta Health Portal

You are about to leave a GSK Website. By clicking this link, you will be taken to an external website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on this site. If you do not wish to leave this website, click on “Go Back” below:

Continue

Go back

MLT_GIB/OTH/0007/17m
Date of preparation: March 2018

GSK routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies and collection of reports and cases of adverse event for marketed products.Read more

The information contributes to the continuing safety surveillance of our products. If you become aware of a patient who has experienced an adverse event, pregnancy, overdose or unexpected benefits with one of our products, we would be grateful if you would contact your local GlaxoSmithKline office or complete the form below. GSK will only use your details to contact you about your adverse event report.